Renowned C15:0 Researcher, Dr. Stephanie Venn-Watson, to Headline at Dr. Seeds SSRP 2023 Peptide World Congress 2023

Dr. Venn-Watson, co-founder of Seraphina Therapeutics, will discuss how fatty15 is emerging as an essential longevity-supporting supplement SAN DIEGO, Aug. 17, 2023 /PRNewswire-PRWeb/ -- The scientific community is abuzz with anticipation as Dr. Stephanie Venn-Watson, the world's foremost...
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Tags: SVY Source Type: news